Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| CHMFL-EGFR-202 | C25H24ClN7O2 | 2089381-40-6 | Details |
| CHMFL-PI3KD-317 | C21H24ClN5O3S2 | 2244992-76-3 | Details |
| Cholesteryl Linolenate | C45H74O2 | 2545-22-4 | Details |
| Cholesteryl arachidonate | C47H76O2 | 604-34-2 | Details |
| Naftidrofuryl oxalate | C26H35NO7 | 3200-06-4 | Details |
| Cipropride S enantiomer | C17H25N3O4S | 66183-70-8 | Details |
| Ciraparantag；PER977 | C22H48N12O2 | 1438492-26-2 | Details |
| Ciraparantag TFA；PER977 TFA | C24H49F3N12O4 | 1438492-27-3 | Details |
| Cicloprolol hydrochloride | C18H30ClNO4 | 63686-79-3 | Details |
| Theophylline | C7H8N4O2 | 58-55-9 | Details |
| Clocapramine dihydrochloride hydrate；3-Chlorocarpipramine hydrochloride hydrate;Clocapramine hydrochloride hydrate | C28H40Cl2N4O2 | 60789-62-0 | Details |
| CP-547632 | C20H24BrF2N5O3S | 252003-65-9 | Details |
| CPPG；(RS)-CPPG | C11H14NO5P | 183364-82-1 | Details |
| CPFX2090 | C28H28ClNO6 | 1429439-25-7 | Details |
| CPA inhibitor | C18H19NO4 | 223532-02-3 | Details |
| CPDA | C20H15ClF2N2O2 | 1415834-63-7 | Details |
| Repaglinide | C27H36N2O4 | 135062-02-1 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| CP-96486 | 139401-45-9 | Details |
| Corin | C26H28N4O2 | 1808113-09-8 | Details |
| Vitamin D2 | C28H44O | 50-14-6 | Details |
| Collagen proline hydroxylase inhibitor | C18H18N4O4 | 223666-07-7 | Details |
| Collagen proline hydroxylase inhibitor-1 | C24H21N5O4 | 223663-32-9 | Details |
| Closthioamide | C29H38N6O2S6 | 1227367-59-0 | Details |
| CP-28888；CP 28888-27 | C40H76N2 | 69938-75-6 | Details |
| Cot inhibitor-1 | C27H27Cl2FN8 | 915365-57-0 | Details |
| Citrinin；NSC 186 | C13H14O5 | 518-75-2 | Details |
| Cl-amidine TFA | C14H19ClN4O2 ? CF3CO2H | 1043444-18-3 | Details |
| Chromomycin A3 | C57H82O26 | 7059-24-7 | Details |
| CK-666 | C18H17FN2O | 442633-00-3 | Details |
| CL 316243 | C20H18ClNO7.2Na | 138908-40-4 | Details |
| Cirsimarin | C23H24O11 | 13020-19-4 | Details |
| Chymase-IN-1 | C20H15ClNO4PS | 862090-74-2 | Details |
| Cilobradine hydrochloride | C28H38N2O5.ClH | 186097-54-1 | Details |
| Benzyl isothiocyanate | C8H7NS | 622-78-6 | Details |
| Cirsiliol | C17H14O7 | 34334-69-5 | Details |
| Cletoquine | C16H22ClN3O | 4298-15-1 | Details |
| CL2-SN-38 | C82H106N12O23 | 1036969-20-6 | Details |
| CL264 | C19H23N7O4 | 1510712-69-2 | Details |
| CL656；c-[2’FdAMP(S)-2’FdIMP(S)] | C20H21F2N9O9P2S2 | 1951464-79-1 | Details |
| CM-675 | C31H32N6O3 | 1872466-47-1 | Details |
| CM-579 | C29H40N4O3 | 1846570-40-8 | Details |
| CP-809101 hydrochloride | C15H18Cl2N4O | 1215721-40-6 | Details |
| CNS-5161 hydrochloride | C16H19Cl2N3S2 | 160756-38-7 | Details |
| CPPHA | C22H15ClN2O4 | 693288-97-0 | Details |
| CPUY074020 | C25H28N4O2 | 902279-44-1 | Details |
| Valacyclovir hydrochloride | C13H20N6O4.ClH | 124832-27-5 | Details |
| Cot inhibitor-2 | C26H25Cl2FN8 | 915363-56-3 | Details |
| CP-409092 | C17H19N3O2 | 194098-25-4 | Details |
| CP-409092 hydrochloride | C17H20ClN3O2 | 225240-86-8 | Details |
| Complement C5-IN-1 | C24H32N2O6 | 2365402-67-9 | Details |
| CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
| Coenzyme A | C21H36N7O16P3S | 85-61-0 | Details |
| Cobimetinib (R-enantiomer)；XL-518 R-enantiomer;GDC-0973 R-enantiomer;Cobimetinib R-enantiomer | C21H21F3IN3O2 | 934660-94-3 | Details |
| CMP-Sialic acid sodium salt；CMP-Neu5Ac sodium salt | C20H32N4NaO16P | 1007117-62-5 | Details |
| CMI-392 | C31H37ClN2O8S | 205654-37-1 | Details |
| Clomipramine D3 hydrochloride | C19H24Cl2N2 | 1398065-86-5 | Details |
| CNT2 inhibitor-1 | C23H24N6O4 | 880155-70-4 | Details |
| COH34 | C18H15NOS | 906439-72-3 | Details |
| Glutathione oxidized | C20H32N6O12S2 | 27025-41-8 | Details |
| CMLD012072 | C32H32N2O7 | 2368900-33-6 | Details |
| L-Glutathione reduced | C10H17N3O6S | 70-18-8 | Details |
| CMP-5 | C21H21N3 | 880813-42-3 | Details |
| CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
| CMK | C18H19ClN4O2 | 821794-90-5 | Details |
| CLK1-IN-1 | C24H16FN5O | 2123491-32-5 | Details |
| Theophylline monohydrate | C7H10N4O3 | 5967-84-0 | Details |
| Apramycin sulfate | C21H43N5O15S | 65710-07-8 | Details |
| CMLD010509；SDS-1-021 | C27H26BrNO7 | 256497-58-2 | Details |
| CO23 | C19H18I2N2O4 | 1370363-74-8 | Details |
| COH34 analog 1 | C18H15NO3S | 314248-24-3 | Details |
| Cletoquine oxalate；Desethylhydroxychloroquine oxalate | C18H24ClN3O5 | 14142-64-4 | Details |
| CMLD012612 | C31H33N3O7 | 2368900-35-8 | Details |
| Col003 | C14H11NO4 | 328565-16-8 | Details |
| CP-547632 hydrochloride | C20H25BrClF2N5O3S | 252003-71-7 | Details |
| CRAC intermediate 1 | C10H7F2N3O | 1249343-86-9 | Details |
| CRA-026440 | C23H24N4O4 | 847460-34-8 | Details |
| CNX-500 | C48H68N10O9S | 1202758-21-1 | Details |
| Clomipramine D3 | C18H19ClD3N3 | 136765-29-2 | Details |
| Clocapramine；Clocarpramine;3-Chlorocarpipramine | C28H37ClN4O | 47739-98-0 | Details |
| Clozic | C17H17ClO3 | 22494-47-9 | Details |
| cis-Urocanic acid | C6H6N2O2 | 7699-35-6 | Details |
| Cinacalcet metabolite M4 | C10H12F3N | 104774-87-0 | Details |
| Cl-amidine hydrochloride | C14H20Cl2N4O2 | 1373232-26-8 | Details |
| CKI-7 free base；CKI-7 | C11H12ClN3O2S | 120615-25-0 | Details |
| CHPG | C8H8ClNO3 | 170846-74-9 | Details |
| CP-060 | C30H42N2O5S | 180090-15-7 | Details |
| trans-Pralsetinib；cis-Pralsetinib;cis-BLU-667 | C27H32FN9O2 | 2097132-93-7 | Details |
| CK2/ERK8-IN-1 | C11H9Br4N3O2 | 1085822-09-8 | Details |
| CK2/PIM1-IN-1 | C15H9NO4S2 | 292640-28-9 | Details |
| Cinnarizine D8 | C26H28N2 | 1185242-27-6 | Details |
| Cipemastat；Ro 32-3555 | C22H36N4O5 | 190648-49-8 | Details |
| Cl-amidine | C14H19ClN4O2 | 913723-61-2 | Details |
| Cinnamoylglycine | C11H11NO3 | 16534-24-0 | Details |
| CHMFL-KIT-033 | C23H18FN5O2 | 2351801-41-5 | Details |
| Cholesterol glucuronide | C33H54O7 | 17435-78-8 | Details |
| CHMFL-ABL/KIT-155；CHMFL-ABL-KIT-155 | C33H38F3N5O3 | 2081093-21-0 | Details |
| CHPG sodium salt | C8H7ClNNaO3 | 1303993-73-8 | Details |
| CMF019 | C25H33N3O3S | 1586787-08-7 | Details |
| Coumetarol；Ph 137;Dicumoxane | C21H16O7 | 4366-18-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 | ||||